Covid-19 roundup: Scientists pull pre-print with inflated incidence of myocarditis post mRNA vaccine; AstraZeneca seeks EUA for long-acting antibody
Canadian scientists recently withdrew an alarming pre-print manuscript that mistakenly said the incidence of the heart condition myocarditis was a lot more frequent than actually identified following vaccination with either Moderna’s or Pfizer’s mRNA shot.
“In order to avoid misleading either colleagues or the general public and press, we the authors unanimously wish to withdraw this paper on the grounds of incorrect incidence data. We thank the many peer reviewers who went out of their way to contact us and point out our error. We apologize to anyone who may have been upset or disturbed by our report,” they wrote in an update.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.